Implantation involves the attachment of the blastocyst to the uterine epithelium. However, in humans and also in domestic animals the failure rate for this process is high. Although the reasons for this are unclear, two factors are necessary for success: the production of a hatched blastocyst capable of implanting and, at the same time, the development of an endometrium that is receptive to the embryo.
Implantation involves the attachment of the blastocyst to the uterine epithelium. However, in humans and also in domestic animals the failure rate for this process is high. Although the reasons for this are unclear, two factors are necessary for success: the production of a hatched blastocyst capable of implanting and, at the same time, the development of an endometrium that is receptive to the embryo.
Overall responsibility for the coordination of these two processes lies with the ovarian hormones, oestrogen and progesterone. However, it is now clear that under their influence, locally acting soluble factors secreted by the endometrium can act on the embryo to influence its development. Developing embryos, in turn, have been shown to produce soluble factors that can act in an autocrine manner, or on the endometrium to influence receptivity (Adamson, 1993; Guidice, 1994) . After attachment, embryonic signals also initiate the process of decidualization, by which the endometrium prepares for development of the placenta. Factors involved in the conversation between embryo and endometrium include prostaglandins, leukotrienes, growth factors and cytokines. This article will review new data indicating a critical role for cytokines and growth factors, both in preimplantation embryo development and endometrial receptivity. The aim is to provide an overview of the approaches that have been taken, with a critical appraisal of the methods used and likely future developments.
Cytokines and preimplantation embryo development
After fertilization, preimplantation embryos from several species can develop in simple defined medium to produce viable blastocysts (Bowman and McLaren, 1970) . However, the growth rate in vitro is slower than in in vivo counterparts, and even short periods of culture in vitro followed by embryo replacement results in developmental delay and reduced implantation rates (Vanderhyden and Armstrong, 1988) . In response to these problems, many workers have adopted co-culture systems in which embryos are grown with feeder cell layers, or conditioned medium from them. The effects on embryo development vary greatly depending on the particular combination of medium and cell line used, but good results have been obtained with epithelial cell layers from the uterus or oviduct (Menezo et al., 1990) . Similarly, culture of embryos in media conditioned by other embryos or co-culture of multiple embryos together in the same drop improve development (Keefer et al., 1994) . These early observations suggested that soluble factors secreted by
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Expression of cytokines and their receptors by preimplantation embryos
Extremely sensitive bioassays and ELISAs have been developed to determine which growth factors are produced by preimplantation embryos. Although the majority of studies are in mice and humans, information is now accumulating from several other species. The technique of reverse transcriptasepolymerase chain reaction (RT-PCR) has provided a method by which the expression of the mRNA encoding any growth factor or receptor of known gene sequence can be examined even in very small numbers of purified cells. This method is sufficiently sensitive to detect cytokine and receptor mRNAs from single oocytes and embryos (Sharkey et al., 1995) . The basic steps in the method (Fig. 1 ) and the use of RT-PCR to examine expression of the mRNA for interleukin 6 (IL-6) and its receptor (IL-6R) in human preimplantation embryos (Fig. 2) are shown. Initially, cDNA from each embryo was tested with primers for the housekeeping gene, histidyl tRNA synthetase (His tRNA), to confirm successful RNA isolation and reverse transcription. The mRNAs for both IL-6 and IL-6R were not detected before the blastocyst stage, indicating that embryos cannot respond to IL-6 until this stage. In situ hybridization and immunocytochemistry have also been used to localize mRNA expression in embryos. For example, mRNA encoding leukaemia inhibitory factor (LIF) has been localized to the trophectoderm in mouse embryos, whereas components of the LIF receptor (LIF-Rβ and gp130) are expressed by the inner cell mass (Nichols et al., 1996) . Such studies provide direct evidence for cytokinereceptor interactions within the blastocyst.
This type of analysis has allowed a phenotypic map to be developed of the normal expression pattern of cytokine and receptor mRNAs for several species, including mouse, human, sheep and bovine embryos (Watson et al., 1992 (Watson et al., , 1994 Adamson, 1993; Sharkey et al., 1995) . The results obtained for selected growth factors are shown (Table 1) . Although not complete, the factors shown were chosen because they have been studied by RT-PCR (the most sensitive technique) in several species. The following conclusions can be made. First, the expression of some cytokines or receptors differs among species. Mouse and sheep embryos express LIF, whereas human embryos do not (Table 1) . Therefore, the autocrine and paracrine signals operating at these apparently very similar embryonic stages differ in important respects between species. Second, significant differences in cytokine mRNAs expressed by mouse embryos in vivo and in vitro have been detected (Kelly et al., 1990) . This indicates that results obtained for human embryos in vitro cannot be reliably extrapolated to the situation in vivo.
Functions of growth factors in preimplantation embryos
With the advent of purified or recombinant growth factors, functional studies to determine the roles these may play in the development of embryos or receptivity have involved culture of embryos or endometrium in vitro, in media supplemented with the growth factors. Effects on the synthesis of specific mRNA and protein species, cell division, blastocyst expansion and zona hatching have been shown in several species (reviewed by Adamson, 1993) . For example, human embryos cultured in LIF exhibit increased rates of blastocyst formation and hatching (Dunglison et al., 1996) . However, the mechanisms by which growth factors bring about these effects and their true importance in vivo remain to be elucidated. A second area in which growth factors play an important role is in signalling between the blastocyst and the endometrium before attachment. In mice, blastocyst attachment occurs late on day 4 of pregnancy, and coincides with increased vascular permeability at this site (Psychoyos, 1986) . Local upregulation of the mRNA encoding heparin-binding epidermal growth factor (HB-EGF) occurs in the luminal epithelium of the mouse uterus some 6 h before attachment (Das et al., 1994) . This upregulation is induced by an activated blastocyst at the site of its apposition, even before zona dissolution, suggesting that an embryo-derived soluble factor is responsible. Since this cascade of events is initiated by nidatory oestrogen, it demonstrates how growth factors act as mediators of steroid actions during implantation. In vitro, the effect of HB-EGF is to enhance blastocyst hatching and trophoblast outgrowth through phosphorylation of the EGF receptor on the blastocyst. Other effects may include the induction of adhesion molecules such as perlecan on the surface of the blastocyst, which occurs at this time, and which correlates with the acquisition of attachment competence (Carson et al., 1993) .
Embryo attachment
After the development of a hatched blastocyst, the next step in implantation is the attachment of the embryo to a receptive uterine epithelium. Embryos transferred to the endometrium outside of the normal period fail to implant, indicating that the endometrium is normally resistant to attachment. This has given rise to the concept of a window of receptivity during which time the endometrium will allow implantation. In mice and rats this occurs between day 4 and day 5 of pregnancy (Psychoyos, 1986) . In humans, similar embryo transfer experiments after in vitro fertilization (IVF) indicate that the implantation window occurs between day 19 and day 24 of a normal 28 day cycle (Bergh and Navot, 1992) .
Attempts to define what constitutes a receptive endometrium have pursued two approaches. In the first, researchers have sought to correlate physical changes in the endometrium identified by light or electron microscopy with the proposed period of endometrial receptivity. The second approach is based on the hypothesis that steroids upregulate adhesion molecules on the endometrium or the blastocyst which bind directly to their cognate ligands on the other epithelial surface (Aplin, 1996) . Once in close contact, a cascade of events is triggered possibly similar to that involved in leucocyte adhesion to blood vessels (Springer, 1994) . This brings about the final attachment of the blastocyst and subsequent trophoblast invasion. In addition, downregulation of attachment inhibiting molecules such as mucins may also be important (Surveyor et al., 1995) . Hence, many studies have compared groups of fertile and infertile women in order to define a physical or molecular marker correlating with implantation competence. The assumption is made that abnormal local expression or responses to such growth factors may be responsible for the failure to develop a receptive endometrium. Tseng et al. (1996) have shown that IL-6 secretion by stromal cells from women with endometriosis (frequently associated with infertility) is increased compared with controls. Thus, evidence is beginning to emerge of differences in growth factor expression between fertile and infertile groups of patients, although the significance of this is unclear.
Morphological markers of endometrial receptivity
The apical plasma membrane of luminal epithelial cells has been most closely studied since it is this surface to which blastocyst attachment occurs. There is evidence from many species that marked changes in membrane morphology occur during the period of uterine receptivity. Particular interest has focussed on pinopodes, first described in rodents, which are large cytoplasmic projections from the uterine epithelium. These were visualized by scanning electron microscopy and their presence was found to correspond closely to the period of endometrial receptivity defined by embryo transfer (reviewed in Murphy, 1995) . In human endometrium, they persist for 24-48 h, between day 19 and day 21 of the cycle (Psychoyos and Nikas, 1994) . In rodents, they have been shown to be involved in pinocytosis of luminal fluid, but such a role in human endometrium is unproven. Although their importance to implantation is unclear, they appear to provide a useful morphological correlate of the receptive state. Their appearance in rats is induced by progesterone, whereas oestrogen induces their regression (Martel et al., 1991) . It is not known whether growth factors play a role in this regulation.
Adhesion molecules in the uterine epithelium
The expression of a variety of adhesion molecules that may mediate blastocyst epithelial interactions has been studied (reviewed by Aplin, 1996) . In particular, the integrins, which mediate adhesion to extracellular matrix (ECM) components, have been studied extensively in both normal and infertile women. Although some integrins are expressed in a cyclespecific manner, their regulation in glandular and luminal 54
A. Sharkey epithelium frequently differs. Particular interest has focused on the integrin heterodimer αvβ3, which appears in both luminal and glandular epithelium at day 19, and persists throughout the luteal phase (Lessey et al., 1995) . This molecule binds via an Arg-Gly-Asp motif (RGD) to osteopontin, which may form a bridging molecule with αvβ3 and which is also expressed on human and mouse embryos (Sutherland et al., 1993; Campbell et al., 1995) . Osteopontin is expressed by the uterine epithelium at this time (Brown et al., 1992) . Women with unexplained infertility show a failure to upregulate αvβ3 on day 19, indicating that αvβ3 upregulation in the endometrium may correlate with the start of endometrial receptivity (Lessey et al., 1995) . Other molecules that may modulate embryo endometrial interactions are glycoproteins of the epithelial glycocalyx. In mice, a major surface-associated mucin (MUC-1) is downregulated at the time of implantation (Surveyor et al., 1995) . Large molecules such as MUC-1 have been shown to interfere with cell-cell interactions through steric hindrance. Downregulation at implantation may allow blastocyst attachment. However, in human endometrium, MUC-1 is abundant at the time of implantation (Hey et al., 1994) . Direct evidence for the involvement of oligosaccharides comes from experiments in which implantation is blocked by antibodies against the oligosaccharide determinant Lewis y (Zhu et al., 1995) .
Morphological and molecular markers the expression of which correlates with implantation are beginning to be found. However, knowledge about the molecular basis of receptivity is still rudimentary, and all that can be said is that these may provide correlative markers for the receptive state. Whether pinopodes, integrins or glycoproteins have an important functional role in implantation is unclear. Mouse strains deleted for specific integrin genes have been created, allowing functional analysis. The blastocysts of mice lacking a functional β1 integrin gene attach to and penetrate uterine epithelium, but trophoblast migration fails at this stage (Fassler and Meyer, 1995) . However, the majority of knockout mice, deleted for individual integrins show no defects in the attachment and early stages of implantation (Hynes, 1996) . This apparent redundancy is similar to that exhibited by cytokine networks, and probably occurs because several integrins are able to bind each of the ECM components. Analysis of their functions are further complicated by the variations in expression between the fundus and isthmus of the human uterus, and even local mosaicism in the luminal epithelium in a given area of the endometrium (Behzad et al., 1994) . Perhaps reflecting these problems, very little is known regarding the regulation of integrins and glycoproteins by growth factors in the endometrium. Although integrin expression is readily altered by growth factors in many cell types, there is no information about how they regulate integrins in endometrial epithelium. Steroid hormones have been shown to have no effect on integrin expression by stromal cells in vitro, but EGF did increase expression of the α1β1 collagen receptor, suggesting that growth factors may play a role in integrin changes through the cycle (Grosskinsky et al., 1996) .
Functional analysis of specific cytokines in implantation
There is now a wealth of data regarding the expression of mRNA encoding growth factor receptor and proteins in embryos, and the effects of growth factors on embryo development in vitro. It is perhaps surprising that, even where growth factors such as transforming growth factor α (TGF-α) have been shown to affect embryo development in vitro strongly, gene targetting experiments in vivo indicate that most null mutations for growth factors or receptors have no significant effect on implantation itself, although later development is often affected (Luetteke et al., 1993) . The overall conclusion from these knockouts, together with the studies in vitro is that although many growth factors can affect mouse embryo development in vitro, the majority do not play a vital role in implantation (Tabibzadeh and Babaknia, 1995) . Nonetheless, two ligand-receptor systems that do play a critical role in implantation have been identified: these are LIF and EGF. However, it should be noted that the knockout approach is currently restricted to mice. Phenotypic analysis in vivo in other species using gene deletions awaits the development of the relevant embryonic cell lines. Another major limitation is that, while it is now relatively easy to produce embryos lacking a specific growth factor or receptor gene, it is often impossible to examine the effects of the lack of this gene in the maternal endometrium because many null mutations produce a phenotype incompatible with reproduction in the adult.
Leukaemia inhibitory factor
LIF is a pleiotropic cytokine that was first identified through its induction of differentiation in the M1 cell line (Hilton et al., 1988) . Its best known action is the inhibition of embryonic stem cell differentiation, essential for the production of knockout mice. LIF acts on its target cells by binding to a specific receptor LIF-Rβ. The ligand-receptor complex associates with another membrane-bound protein, gp130, resulting in signal transduction (Gearing et al., 1992) . LIF is a member of a family of cytokines with related structures which includes IL-6, ciliary neurotrophic factor (CNTF), IL-11 and cardiotrophin (Pennica et al., 1995) . These molecules all have gp130 in common as part of the signal transduction complex, which probably accounts for much of their redundancy (see Fig. 3 ). The LIF ligandreceptor system has been particularly well studied since the effects of LIF on the preimplantation embryos of several species are known and knockout mice deleted for all the components (LIF, LIF-R and gp130) have been produced (Stewart et al., 1992; Ware et al., 1995; Yoshida et al., 1996) . In mice, LIF is upregulated in the uterine glandular epithelium on day 4, just before implantation, by the action of nidatory oestrogen (Bhatt et al., 1991) . Female mice lacking a functional LIF gene are unable to support implantation. Although not examined in detail, preimplantation development appears normal since viable blastocysts are produced, which implant normally when transferred to pseudopregnant mothers (Stewart et al., 1992) . However, pregnancies did occur in the LIF -/-females when LIF was infused into the uterine lumen by osmotic pump. These results show that maternal expression of LIF is essential for implantation; however, whether the critical site of action is the preimplantation embryo or the endometrium is not known. In situ hybridization on mouse blastocysts has shown that mRNAs encoding LIF-Rβ and gp130 are expressed only in the inner cell mass, whereas mRNA encoding LIF is present in the trophectoderm (Nichols et al., 1996) . Administration of exogenous LIF improves embryo viability and hatching, and overexpression of LIF inhibits the formation of primitive ectoderm (Shen and Leder, 1992; Lavranos et al., 1995) . In the endometrium, LIF-R and gp130 are expressed in luminal epithelium on day 4 and in the stroma on day 5 (Yang et al., 1995a) . Taken together, these data suggest both the preimplantation embryo and the maternal endometrium as sites for the action of LIF. The generation of mice lacking either LIF-Rβ or gp130 receptor components has now resolved this question. Embryos totally lacking either LIF-Rβ or gp130 have now been produced, both of which are able to develop successfully to the blastocyst stage and implant apparently normally. LIF-Rβ -/-mice develop successfully to term, although they exhibit numerous abnormalities, including placental defects (Ware et al., 1995) . As expected, given its involvement in signalling by several cytokines, disruption of the gp130 gene leads to a more severe phenotype, with embryonic lethality between day 12.5 and day 18 of gestation (Yoshida et al., 1996) . Embryo development, attachment and implantation can thus occur without any direct action of maternal uterine LIF on the embryo. Although LIF may have a beneficial effect on embryo development, its vital role in murine implantation is through its actions on endometrial epithelium or stroma or both. LIF -/-mice have been shown to fail to undergo a decidual response after oil injection into the uterus on day 5 of pseudopregnancy (Stewart, 1994) . Thus, LIF may be involved in sensitizing the uterus to the decidualizing signal from the embryo.
Does LIF play a similar role in other species?
Human embryos have been shown to express LIF-Rβ and gp130 mRNAs at the blastocyst stage, but do not themselves express LIF (Sharkey et al., 1995; Seifert et al., 1993) . Administration of LIF to preimplantation human embryos cultured in a defined serum-free system has recently been shown to have a beneficial effect on development (Dunglison et al., 1996) . Expression of mRNA encoding LIF in the endometrium is maximal in the mid-late luteal phase, and strong LIF immunoreactivity is detected in glandular epithelium at this time (Charnock-Jones et al., 1994; Arici et al., 1995) . Although there are some reports of LIF immunoreactivity in stromal cells, epithelial cells secrete more LIF than stromal cells in vitro, suggesting they are the major site of secretion (Vogiagis et al., 1996; Chen et al., 1995) . LIF-Rβ and gp130 mRNAs and LIF binding activity are localized to luminal epithelium of the endometrium throughout the menstrual cycle . This suggests that LIF can act via an autocrine mechanism on the endometrial epithelium as in mice. Binding of leukaemia inhibitory factor (LIF), IL-6, IL-11 and ciliary neurotrophic factor (CNTF) is mediated through ligand-specific receptor subunits, which then trigger association of the other receptor components required for signalling. However, cardiotrophin (CT-1) and oncostatin-M (OSM) appear to compete directly with LIF to the LIFR-β chain. The constitution of the receptor complexes for these two members is still unclear (Pennica et al., 1995) .
A similar pattern of expression is seen in rabbits, with LIF, LIF-Rβ and gp130 co-expressed in epithelium of the endometrium around implantation (Yang et al., 1995b) . In the endometrium of pigs and sheep, maximal expression of LIF is on days 11 and 16-20, respectively. As with human embryos, there is clear evidence for improved development of ovine embryos cultured in the presence of LIF (Anegon et al., 1994; Vogiagis et al., 1997; Fry et al., 1992) . Thus in most species examined to date, there is expression of LIF in the endometrial epithelium with maximal expression at the time of implantation (Box 1). However, the regulation of LIF by steroids differs: in mice, oestradiol is required for implantation and upregulates LIF; in rabbits, oestradiol is not required, and LIF is upregulated by progesterone (Yang et al., 1995b) . Similarly, while there is evidence in several species for a beneficial effect of LIF on embryo development, mouse and sheep embryos themselves make LIF, whereas human embryos do not (Vogiagis et al., 1997; Murray et al., 1990; Sharkey et al., 1995, see Table 1 ). These results show that the autocrine and paracrine circuits of cytokines controlling preimplantation embryo development differ between species.
The epidermal growth factor (EGF) family
The EGF family of growth factors consists of EGF, TGF-α, heparin binding EGF (HB-EGF) and amphiregulin, all of which act through the EGF receptor (EGFR; Massague and Pandiella, 1993) . Members of the EGF family are known to play an important role in the growth and differentiation of the glandular and stromal compartments of the endometrium (Guidice, 1994) . The EGF receptor is also expressed on mouse and human preimplantation embryos, and reported effects of the EGFs on embryos include increased protein synthesis and improved blastocyst development (Adamson, 1993; Chia et al., 1995) . There is also now strong evidence in murids that members of the EGF Expression of HB-EGF is induced exclusively in the luminal epithelium surrounding the blastocyst, several hours before implantation, as discussed above. HB-EGF bound to heparin on the surface of luminal epithelium may be able to interact directly with EGF receptor on the embryonic trophectoderm (Das et al., 1994) . Therefore, the EGF ligands may also be involved in signalling between the embryo and the endometrium at the time of implantation itself. Until recently, direct evidence for a critical role in embryo development or implantation was lacking, particularly since mice deleted for EGF or TGF-α showed no effects on implantation. This is probably due to the redundancy in the family: in the absence of any one ligand, other members of the family are available to bind to the EGFR. However, deletion of the receptor gene has been shown to have serious effects on implantation. The phenotype seen in mice deleted for the EGFR is dependent on the genetic background. On a 129/SV background, EGFR -/-mutants died at midgestation, exhibiting placental defects (Threadgill et al., 1995) . On a CD-1 background, mutants were live-born but showed multiple abnormalities and died before three weeks of age. On the CF-1 background, EGFR -/-embryos hatched and began implantation, but showed reduced and disorganized inner cell masses, and failed to develop further, although trophoblast cells did invade the decidua. The phenotypes were embryodependent and were seen regardless of the maternal genotype. Although the mechanisms by which the genetic background modifies the EGFR -/-phenotype are unknown, in the CF-1 strain it appears that inner cell mass development requires EGFR function, whereas trophectoderm development does not.
Other cytokines involved in implantation
Many other cytokines have been reported to be involved in various aspects of implantation. Two in particular have been extensively studied, because there is strong evidence for a role in implantation in mice. These are interleukin 1 (IL-1) and colony-stimulating factor 1 (CSF-1). However, recent examination of knockout strains lacking CSF-1 or the IL-1 receptor indicate that although these factors can affect the frequency of successful implantation, unlike LIF they are not essential.
The interleukin-1 ligand-receptor system
The IL-1 system consists of two ligands, IL-1α and IL-1β, and a natural receptor antagonist IL-1Ra. Two receptors have been identified to date. The type 1 receptor (IL-1RT1) is widely expressed, and ligand binding results in signal transduction. A second receptor, the 64 kDa type 2 receptor (IL-1RT2) is expressed primarily in leucocytes; however, ligand binding does not appear to result in signalling and its function is unclear. IL-1Ra acts as a complete antagonist preventing IL-1 binding to the receptor (see review by Dinarello, 1992) .
In human endometrium, IL-1α and IL-1β immunoreactivity have been reported in endothelial cells and leucocytes, whereas IL-1RT1 is expressed primarily in the epithelium throughout the menstrual cycle (Simon et al., 1993) . Human preimplantation embryos also secrete IL-α and IL-β into the culture supernatant under some culture conditions, and IL-1RT1 immunostaining has been reported on all stages of human preimplantation embryos (De Los Santos et al., 1995) . In mice, expression of IL-1 ligands and receptors is similar to that observed in humans (summarized in Box 2). IL-1RT1 immunoreactivity is localized primarily in the luminal and glandular epithelium, and is most intense in the epithelium surrounding the implanting blastocyst on day 4 (Simon et al., 1994) . Intraperitoneal injection of recombinant IL-1Ra on days 3-9 of pregnancy was found to block implantation almost completely (Simon et al., 1994) . Morphological studies revealed the presence of unimplanted blastocysts in the uterine lumen on day 7, long after normal implantation should have occurred. This suggests that the IL-1 system plays an important role in embryo attachment in mice. However, in apparent contradiction, mice lacking a functional IL-1 type 1 receptor have been shown to breed normally . One possible explanation is that the above phenotype is strain specific (as for the EGF receptor). The IL-1Ra experiments were performed using C57Bl6/J × CBA hybrids, whereas the IL-1RT1 knockout was in a C57Bl6 × 129Sv hybrid background. Experiments on other genetic backgrounds will be necessary to 
Colony-stimulating factor 1
A role for CSF-1 in implantation was first postulated when it was found that concentrations in the mouse uterus increase by 1000 times during pregnancy (Bartocci et al., 1986) . Furthermore, the CSF-1 receptor, the proto-oncogene c-fms, is expressed in mouse embryos, and CSF-1 enhances embryo development in vitro (Pampfer et al., 1991) . That CSF-1 has an important role in fertility was suggested by work using a naturally occurring null mutant mouse strain, the op/op or osteopetrotic mouse. Homozygous females crossed to op/op fertile males fail to produce viable offspring, possibly indicating an implantation defect. However female op/op matings to heterozygous op/+ males are viable, although not all mice become pregnant, and those that do exhibit reduced implantation (Pollard et al., 1991) . More detailed studies have shown that both male and female fertility is severely compromised. Male op/op mice exhibit low sperm counts and reduced libido, whereas females have very extended oestrous cycles with poor ovulation. These effects appear to be secondary to failed steroidogenesis in the gonads, possibly resulting from altered macrophage behaviour (Pollard, 1997) . Therefore, op/op mice are not sterile, but their fertility is compromised at several stages throughout the reproductive process in both males and females. This illustrates the pleiotropic nature of cytokine action, and the complex way even a single factor may affect implantation.
Summary and future prospects
Cytokines and growth factors have been shown to act in both an autocrine and paracrine manner to regulate the development of preimplantation embryos. Such factors affect the rate of cell division, differentiation into trophectoderm and ICM, and adhesion to the epithelium of the endometrium. Attempts to define the function of each cytokine have involved receptor localization, and functional assays in vitro and in vivo. To date, these studies have shown that although some growth factors such as LIF may enhance preimplantation embryo development, no single factor has yet been identified which is essential. Furthermore, as the data from the EGFR mouse mutants demonstrate, the effect on embryos of a given null mutation can vary on different genetic backgrounds. Defining the nature of such genetic modifiers may provide important insights into other mechanisms that affect preimplantation embryo development.
Assisted reproduction techniques frequently require maintenance of human oocytes and embryos in vitro before transfer to the uterus. This has led to strong interest in minimizing the loss of viability that this entails. In domestic species, the development of methods for sexing and cloning of embryos and the production of genetically modified animals provides the impetus to improve techniques for maximizing successful implantation after in vitro culture. Future work will focus on defining serum free media containing growth factors that will overcome problems such as embryo arrest, improve viability and hence increase implantation rates.
The endometrium poses a more difficult problem; here the challenge remains to define the nature of receptivity, and to understand embryo-endometrial interactions at the molecular level. It is now well established that local growth factors mediate many of the effects of steroids on the endometrium, such as proliferation, angiogenesis and secretion, as it prepares for implantation. Therefore, the assumption is made that cytokines will also be involved in bringing the endometrium into a receptive state for blastocyst attachment. The identification of LIF as a growth factor the expression of which is essential for implantation in the mouse supports this hypothesis. Although LIF may enhance embryo development, its critical role in mouse implantation appears to be in sensitizing the endometrium to the embryonic signals that initiate decidualization. Considerable effort is now being focused on determining whether LIF plays a similar role in other species such as humans or rabbits, in which progesterone rather than oestrogen controls implantation. Although the steroidal control may be different, the effector may be the same.
In seeking to define which factors may be important in producing a receptive endometrium, many studies are now comparing the synthesis and secretion of growth factors by endometrium from fertile and infertile women. The hypothesis is that factors critical for establishing a receptive endometrium will differ between the two groups. Secretion of LIF by endometrial explants of women with infertility is reduced compared with that of endometrium from normal fertile women. Furthermore, LIF secretion is increased by IL-1 (Delage et al., 1995) . Similarly, IL-6 secretion in vitro is upregulated in ectopic and eutopic endometrium from women with endometriosis (Tseng et al., 1996) . Therefore, results are beginning to emerge that confirm the contention that abnormalities in growth factor expression may underlie endometrial dysfunction.
Research from two further areas is likely to be important in defining which growth factors are important in human implantation. Functional information can occasionally be derived from molecular genetic studies of families with gene mutations in growth factor and adhesion genes. Human null mutations in the genes encoding CNTF, the integrin β3 (proposed as a marker of endometrial receptivity above), and c-kit, the receptor for stem cell factor, have been identified. None of these appear to have any significant effect on implantation (Fleischman, 1993; Hynes, 1996; Takahashi et al., 1996) . As analysis of the genetic basis of human disease becomes more widespread, further individuals will be identified lacking ligand or receptor genes. The reproductive success of such individuals will provide a functional test for the requirement of such genes in implantation. In addition, in vitro three-dimensional culture systems have been established in which epithelial and stromal cells are co-cultured. The epithelial cells exhibit polarity, with microvilli and pinopodes, and closely resemble endometrium in vivo (Bentin-Ley et al., 1994) . These systems offer the potential for studying the local molecular events involved in blastocyst adhesion in vitro, and for elucidating the role played by cytokines in producing an attachment competent luminal epithelium.
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